MBP8298 Clinical Trials
BioMS Medical is currently conducting three late-stage clinical trials and one open-label, follow-on trial of MBP8298, for the treatment of multiple sclerosis.

	Phase III Canadian & European trial for secondary progressive MS
	Phase III U.S. trial for secondary progressive MS
	Phase II relapsing-remitting MS trial